Global analysis of differentially expressed genes in androgen-independent prostate cancer (original) (raw)

• Eisenberger MA, Carducci MA . Chemotherapy for hormone-resistant prostate cancer. In:Walsh PC, Retik AB, Vaughan DE, Wein AJ (eds). Campbells Urology, 8th edn. Elsevier: Philadelphia, 1998, pp 3209–3226.
  Google Scholar
• Logothetis CJ, Hoosein NM, Hsieh JT . The clinical and biological study of androgen independent prostate cancer (AI PCa). Semin Oncol 1994; 21: 620–629.
  CAS Google Scholar
• Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995; 332: 1393–1398.
  Article CAS Google Scholar
• Naslund MJ, Coffey DS . The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. J Urol 1986; 136: 1136–1140.
  Article CAS Google Scholar
• Bektic J, Wrulich OA, Dobler G, Kofler K, Ueberall F, Culig Z et al. Identification of genes involved in estrogenic action in the human prostate using microarray analysis. Genomics 2004; 83: 34–44.
  Article CAS Google Scholar
• Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994; 12: 454–466.
  Article CAS Google Scholar
• Jackson MW, Bentel JM, Tilley WD . Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 1997; 157: 2323–2328.
  Article CAS Google Scholar
• Borre M, Nerstrom B, Overgaard J . Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. Clin Cancer Res 2000; 6: 1882–1890.
  CAS Google Scholar
• Holloway AJ, van Laar RK, Tothill RW, Bowtell DD . Options available-from start to finish-for obtaining data from DNA microarrays II. Nat Genet 2002; 32 (Suppl): 481–489.
  Article CAS Google Scholar
• Li Y, Li Y, Tang R, Xu H, Qiu M, Chen Q et al. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J Cancer Res Clin Oncol 2002; 128: 369–379 [E-pub 20 June 2002].
  Article CAS Google Scholar
• Sambrook J, Russell DW . Using PCR to amplify DNA in vitro. In: Argentine J (ed) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press: NY, 2001.
  Google Scholar
• Berger JA, Hautaniemi S, Jarvinen AK, Edgren H, Mitra SK, Astola J . Optimized LOWESS normalization parameter selection for DNA microarray data. BMC Bioinformatics 2004; 5: 194.
  Article Google Scholar
• Gunawardena RW, Siddiqui H, Solomon DA, Mayhew CN, Held J, Angus SP et al. Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1. J Biol Chem 2004; 279: 29278–29285.
  Article CAS Google Scholar
• Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K et al. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci 2003; 94: 148–152.
  Article CAS Google Scholar
• Ree AH, Bratland A, Nome RV, Stokke T, Fodstad O . Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1. Oncogene 2003; 22: 8952–8955.
  Article CAS Google Scholar
• Liu X, Erikson RL . Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 2003; 100: 5789–5794.
  Article CAS Google Scholar
• Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K et al. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 2004; 60: 240–245.
  Article CAS Google Scholar
• Schafer B, Marg B, Gschwind A, Ullrich A . Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival. J Biol Chem 2004; 279: 47929–47938 [E-pub 26 August 2006].
  Article Google Scholar
• Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J . TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J 2003; 22: 1114–1124.
  Article CAS Google Scholar
• Ding X, Yang LY, Huang GW, Wang W, Lu WQ . ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2735–2739.
  Article CAS Google Scholar
• Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF et al. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. Int J Oncol 2003; 23: 1365–1371.
  CAS Google Scholar
• Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T . Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 2005; 4: 471–476.
  CAS Google Scholar
• Jiang F, Caraway NP, Li R, Katz RL . RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 2005; 24: 3409–3418.
  Article CAS Google Scholar
• Li JQ, Wu F, Masaki T, Kubo A, Fujita J, Dixon DA et al. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors. Int J Oncol 2004; 25: 87–95.
  Google Scholar
• Shigemasa K, Gu L, O'Brien TJ, Ohama K . Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 2003; 9: 1756–1763.
  CAS Google Scholar
• Lu L, Schulz H, Wolf DA . The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC Cell Biol 2002; 3: 22 [E-pub 20 August 2002].
  Article CAS Google Scholar
• Gillette JM, Chan DC, Nielsen-Preiss SM . Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 2004; 92: 820–832.
  Article CAS Google Scholar
• Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, Person MD et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 2003; 22: 1475–1485.
  Article CAS Google Scholar
• Wang HT, Kong JP, Ding F, Wang XQ, Wang MR, Liu LX et al. Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray. World J Gastroenterol 2003; 9: 392–398.
  Article CAS Google Scholar
• Sullivan DC, Huminiecki L, Moore JW, Boyle JJ, Poulsom R, Creamer D et al. EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem 2003; 278: 47079–47088 [E-pub 8 September 2003].
  Article CAS Google Scholar
• Koyama S, Koike N, Adachi S . Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J Cancer Res Clin Oncol 2002; 128: 73–79 [E-pub 12 December 2001].
  Article CAS Google Scholar
• Kim R, Tanabe K, Emi M, Uchida Y, Toge T . Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells. Oncol Rep 2003; 10: 1925–1930.
  CAS Google Scholar
• Li B, Sun M, He B, Yu J, Zhang YD, Zhang YL . Identification of differentially expressed genes in human uterine leiomyomas using differential display. Cell Res 2002; 12: 39–45.
  Article CAS Google Scholar
• Zhang X, Grand RJ, McCabe CJ, Franklyn JA, Gallimore PH, Turnell AS . Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53. Biochem J 2002; 368 (Part 1): 191–201.
  Article CAS Google Scholar
• Graichen R, Liu D, Sun Y, Lee KO, Lobie PE . Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J Biol Chem 2002; 277: 26662–26672 [E-pub 6 May 2002].
  Article CAS Google Scholar
• Berns EM, Dirkzwager-Kiel MJ, Kuenen-Boumeester V, Timmermans M, Verhoog LC, van den Ouweland AM et al. Androgen pathway dysregulation in BRCA1-mutated breast tumors. Breast Cancer Res Treat 2003; 79: 121–127.
  Article CAS Google Scholar
• Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R et al. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2. Cancer Res 2005; 65: 6–10.
  CAS Google Scholar
• Gao B, Shen X, Kunos G, Meng Q, Goldberg ID, Rosen EM et al. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 2001; 488: 179–184.
  Article CAS Google Scholar
• Clark BJ, Li J . Janus kinase 2 signaling in the angiotensin II-dependent activation of StAR expression. Endocr Res 2004; 30: 685–693.
  Article CAS Google Scholar
• Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 2003; 100: 1016–1021 [E-pub 27 January 2003].
  Article CAS Google Scholar
• Leav I, Merk FB, Kwan PW, Ho SM . Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 1989; 15: 23–40.
  Article CAS Google Scholar
• Aguilar R, Bellido C, Benitez de Lupo EA . Differences in prepuberal neonatally estrogenized or androgenized male rats. Andrologia 1987; 19: 183–187.
  Article CAS Google Scholar
• Tynan S, Pacia E, Haynes-Johnson D, Lawrence D, D'Andrea MR, Guo JZ et al. The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium. Endocrinology 2005; 146: 1066–1073.
  Article CAS Google Scholar
• Braidotti P, Nuciforo PG, Mollenhauer J, Poustka A, Pellegrini C, Moro A et al. DMBT1 expression is down-regulated in breast cancer. BMC Cancer 2004; 4: 46.
  Article CAS Google Scholar
• Mollenhauer J, Herbertz S, Helmke B, Kollender G, Krebs I, Madsen J et al. Deleted in 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res 2001; 61: 8880–8886.
  CAS Google Scholar
• Ma JF, Takito J, Vijayakumar S, Peehl DM, Olsson CA, Al-Awqati Q . Prostatic expression of hensin, a protein implicated in epithelial terminal differentiation. Prostate 2001; 49: 9–18.
  Article CAS Google Scholar
• Jung DJ, Sung HS, Goo YW, Lee HM, Park OK, Jung SY et al. Novel transcription coactivator complex containing activating signal cointegrator 1. Mol Cell Biol 2002; 22: 5203–5211.
  Article CAS Google Scholar
• Palmer DH, Hussain SA, Ganesan R, Cooke PW, Wallace DM, Young LS et al. CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule. Oncol Rep 2004; 12: 679–682.
  CAS Google Scholar
• Yamaguchi H, Tanaka F, Sadanaga N, Ohta M, Inoue H, Mori M . Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells. Int J Oncol 2003; 23: 1697–1702.
  CAS Google Scholar
• Deregibus MC, Buttiglieri S, Russo S, Bussolati B, Camussi G . CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem 2003; 278: 18008–18014.
  Article CAS Google Scholar
• Cao LP, Bolt MJ, Wei M, Sitrin MD, Chun Li Y . Regulation of calbindin-D9k expression by 1,25-dihydroxyvitamin D(3) and parathyroid hormone in mouse primary renal tubular cells. Arch Biochem Biophys 2002; 400: 118–124.
  Article CAS Google Scholar
• Komatsu K, Murata K, Kameyama M, Ayaki M, Mukai M, Ishiguro S et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology 2002; 63: 192–200.
  Article CAS Google Scholar
• Srinivasan S, Bunch DO, Feng Y, Rodriguiz RM, Li M, Ravenell RL et al. Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. Endocrinology 2004; 145: 2023–2034 [E-pub 8 January 2004].
  Article CAS Google Scholar
• Hougaard DM, Larsson LI . Carboxypeptidase E in rat antropyloric mucosa: distribution in progenitor and mature endocrine cell types. Histochem Cell Biol 2004; 121: 55–61 [E-pub 6 Decemebr 2003].
  Article CAS Google Scholar
• Slongo ML, Zampieri M, Onisto M . Expression of matrix metalloproteases (MMP-2, MT1-MMP) and their tissue inhibitor (TIMP-2) by rat sertoli cells in culture: implications for spermatogenesis. Biol Chem 2002; 383: 235–239.
  Article CAS Google Scholar
• Ylitalo K, Nuotio I, Viikari J, Auwerx J, Vidal H, Taskinen MR . C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients. Metabolism 2002; 51: 664–670.
  Article CAS Google Scholar
• Bednarek MA, Feighner SD, Hreniuk DL, Palyha OC, Morin NR, Sadowski SJ et al. Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2. Biochemistry 2001; 40: 9379–9386.
  Article CAS Google Scholar
• Fernandez A, Udagawa T, Schwesinger C, Beecken W, Achilles-Gerte E, McDonnell T et al. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer Inst 2001; 93: 208–213.
  Article CAS Google Scholar
• Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9: 407–415.
  Article CAS Google Scholar
• Cross NA, Chandrasekharan S, Jokonya N, Fowles A, Hamdy FC, Buttle DJ et al. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate 2005; 63: 269–275.
  Article CAS Google Scholar
• Darnton SJ, Hardie LJ, Muc RS, Wild CP, Casson AG . Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis. Int J Cancer 2005; 115: 351–358.
  Article CAS Google Scholar
• Miyazaki T, Kato H, Nakajima M, Faried A, Takita J, Sohda M et al. An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. Br J Cancer 2004; 91: 1556–1560.
  Article CAS Google Scholar